Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Medical Economics|October 15, 2011
Evaluating medical resource utilization and costs associated with thrombocytopenia in chronic liver disease patientsFred Poordad, Dickens Theodore, Jane Sullivan, et al.
Journal of Medical Economics|February 26, 2011
Medical resource utilisation and healthcare costs in patients with chronic hepatitis C viral infection and thrombocytopeniaFred Poordad, Dickens Theodore, Jane Sullivan, et al.
Antimicrobial Agents and Chemotherapy|August 27, 2014
Lack of clinically significant pharmacokinetic interaction between the thrombopoietin receptor agonist eltrombopag and hepatitis C virus protease inhibitors boceprevir and telaprevirMary Beth Wire, Lei Fang, Azra Hussaini, et al.
Advances in Therapy|July 23, 2014
Thromboembolic events among patients with hepatitis C virus infection and cirrhosis: a matched-cohort studyCheryl Enger, Ulla M Forssen, Dimitri Bennett, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2022
Comparison of Pharmacokinetics of the GalNAc-Conjugated Antisense Oligonucleotide GSK3389404 in Participants with Chronic Hepatitis B Infection across the Asia-Pacific RegionKelong Han, Hiroshi Ito, Robert Elston, et al.
Antimicrobial Agents and Chemotherapy|March 7, 2012
Assessment of the pharmacokinetic interaction between eltrombopag and lopinavir-ritonavir in healthy adult subjectsMary B Wire, Heidi B McLean, Carolyn Pendry, et al.
Advances in Therapy|July 1, 2023
B-Clear Phase 2b Study Design: Establishing the Efficacy and Safety of Bepirovirsen in Patients with Chronic Hepatitis B Virus InfectionJennifer Cremer, Robert Elston, Fiona M Campbell, et al.
Annals of Hepatology|April 20, 2011
Hepatobiliary laboratory abnormalities among patients with chronic or persistent immune thrombocytopenia (ITP)Cheryl Enger, Dimitri Bennett, Katie L Dawson, et al.
Health and Quality of Life Outcomes|March 24, 2016
Health-related quality of life in thrombocytopenic patients with chronic hepatitis C with or without cirrhosis in the ENABLE-1 and ENABLE-2 studiesKelly M Grotzinger, Zobair M Younossi, Edoardo G Giannini, et al.
Journal of Gastroenterology and Hepatology|August 5, 2014
Severity of liver disease among chronic hepatitis C patients: an observational study of 4594 patients in five European countriesPatrick Marcellin, Kelly Grotzinger, Dickens Theodore, et al.
Pageof 5